Tsingke Congratulates iGEM 2023 SYSU-Software on Winning GOLD MEDAL for BioRocket Project

December 18, 2023 02:13 PM GMT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Tsingke Congratulates iGEM 2023 SYSU-Software on Winning GOLD MEDAL for BioRocket Project
Image source: Kalkine Media

BEIJING and PARIS, Dec. 18, 2023 /PRNewswire/ -- The 2023 International Genetically Engineered Machine Competition (iGEM), the global synthetic biology competition, concluded on November 5, 2023. Over 7,000 students from high schools and universities, organized into more than 400 teams worldwide, participated in this prestigious event. Among them, the Sun Yat-sen University Software Team (iGEM 2023 SYSU-Software), sponsored by Tsingke, achieved the IGEM GOLD MEDAL for their project "BioRocket: Systematic Discovery of Novel Protein Delivery Systems in Massive Prokaryotic Genomes."

The project focused on extracellular Contractile Injection Systems (eCISs), syringe-like protein complexes capable of injecting proteins into cells. Despite their potential as programmable protein delivery tools, only a limited number of eCISs have been characterized to date.

The iGEM 2023 SYSU-Software team developed the BioRocket platform to systematically explore eCISs within prokaryotic genomes using machine learning and structural computation. They also conducted high-throughput predictions of programmable targeting regions within eCISs. The project yielded impressive results, as BioRocket explored over 80,000 prokaryotic organisms, identifying 5,524 novel eCISs. Subsequent wet lab experiments were conducted to validate these novel eCISs identified by BioRocket.

Tsingke played a crucial role by leveraging its technical expertise, providing support, and assisting the team in completing related research on potential EATs genes. The company also verified the identified genes' role as eCIS effector genes.

We aspire that our backing of iGEM 2023 SYSU-Software will inspire more individuals to commit themselves to the research of synthetic biology, contributing to the advancement of this industry.

About iGEM

The iGEM competition is an internationally renowned academic competition in the field of synthetic biology. It was initiated by the Massachusetts Institute of Technology (MIT) in the United States in 2003. It is a comprehensive international competition that revolves around synthetic biology and integrates various disciplines such as life sciences, mathematics, engineering, information science, and art design. The competition has gained widespread attention and special coverage from academic journals such as Nature, Science, Scientific American, The Economist, as well as media outlets like the BBC.

About Tsingke

Tsingke's Gene Factory integrates in-house production of synthetic raw materials and related equipment, and establishes an independent factory-style service model covering the entire nucleic acid synthesis industrial chain.

By continuously researching and upgrading our synthesizers and synthetic materials for oligo production, our gene factory ensures the production of highly accurate oligos. This, in turn, guarantees stable and efficient gene synthesis with timely delivery. The plasmids Tsingke construct undergo NGS and Sanger sequencing validation to ensure 100% sequence accuracy.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

AI on the Rise: A Look at Top AI Companies and Their Stocks

Recent Articles

Investing Tips

Previous Next